AbbVie Inc (TSX:ABBV)
C$ 35.51 -1.4 (-3.79%) Market Cap: 592.81 Bil Enterprise Value: 683.00 Bil PE Ratio: 123.73 PB Ratio: 0 GF Score: 81/100

Abbvie Inc to Acquire Apogee Therapeutics Call Transcript

Jun 22, 2026 / 01:00 PM GMT
Release Date Price: C$32.11 (+5.94%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ABBV.N - Abbvie Inc
Abbvie Inc to Acquire Apogee Therapeutics Call
Jun 22, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and thank you for standing by. Welcome to the AbbVie Investor and Analyst Conference Call. All participants will be able to listen-only until the question-and-answer portion of this call. You may ask a question by pressing star 1 on your phone. As a reminder, this call is being recorded. I would now like to introduce Ms. Li Shea, Senior Vice President, Investor Relations.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning, and thank you for joining us for this special conference call to discuss AbbVie's acquisition of Apogee Therapeutics, which we announced earlier
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot